| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $23.12M | - | |
| Other | 52.8K | $8.69M | - | |
| Other | 46.8K | $7.70M | - | |
| Other | 39.6K | $6.53M | -36,937 | |
| Other | 36.8K | $6.07M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2019 | Lyons Gary A54 | Director | Sell | 5,000 | $110.00 | $550,000.00 | -2.2% | |
| Nov 1, 2019 | Lyons Gary A54 | Director | Sell | 5,000 | $100.22 | $501,103.50 | -2.1% | |
| Nov 1, 2019 | Grigoriadis Dimitri E. | Chief Research Officer | Sale+OE | 10,188 | $100.34 | $1,022,297.54 | -8.6% | |
| Oct 14, 2019 | Lloyd-Smith Malcolm49 | Chief Regulatory Officer | Sale+OE | 9,956 | $90.85 | $904,486.67 | -33.7% | |
| Oct 2, 2019 | Cooke Julie59 | Chief Human Resources Officer | Sell | 987 | $88.56 | $87,408.72 | -23.2% | |
| Sep 3, 2019 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 6,736 | $100.00 | $673,600.00 | -25.1% | |
| Aug 27, 2019 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 3,264 | $100.05 | $326,554.92 | -7.6% | |
| Aug 8, 2019 | Gorman Kevin Charles55 | Chief Executive Officer | Sale+OE | 80,000 | $95.31 | $7,624,974.50 | -6.0% | |
| Jul 30, 2019 | Lyons Gary A54 | Director | Sell | 10,000 | $92.07 | $920,686.00 | -4.1% | |
| Jul 30, 2019 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 15,831 | $92.13 | $1,458,568.60 | -44.2% |